Key result
A phenotype-oriented diagnostic approach and targeted cardioprotective mitochondrial therapy with Neoton are discussed for managing HFpEF in patients with unexplained exertional dyspnea.
This review highlights a phenotype-oriented approach to diagnosing and treating HFpEF, emphasizing inflammatory-metabolic and mitochondrial phenotypes and potential targeted therapies like phosphocreatine.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ларина et al. (2022) conducted a review in Heart failure with preserved left ventricular ejection fraction (HFpEF). Phenotype-based diagnostic approach and Neoton therapy was evaluated. A phenotype-oriented diagnostic approach and targeted cardioprotective mitochondrial therapy with Neoton are discussed for managing HFpEF in patients with unexplained exertional dyspnea.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: